Equivalence of Boosted Atazanavir Based Regimens and Currently Effective HAART Regimens

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Bristol-Myers Squibb
Information provided by (Responsible Party):
Janice Piatt, Phoenix Children's Hospital
ClinicalTrials.gov Identifier:
NCT00940771
First received: July 15, 2009
Last updated: October 21, 2015
Last verified: October 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)